evertex fabrinology limited

TWSE:1470 Stock Report

Market Cap: NT$1.7b

evertex fabrinology Balance Sheet Health

Financial Health criteria checks 6/6

evertex fabrinology has a total shareholder equity of NT$985.3M and total debt of NT$35.0M, which brings its debt-to-equity ratio to 3.6%. Its total assets and total liabilities are NT$1.1B and NT$160.1M respectively. evertex fabrinology's EBIT is NT$33.4M making its interest coverage ratio -3.9. It has cash and short-term investments of NT$445.3M.

Key information

3.6%

Debt to equity ratio

NT$35.00m

Debt

Interest coverage ratio-3.9x
CashNT$445.31m
EquityNT$985.32m
Total liabilitiesNT$160.11m
Total assetsNT$1.15b

Recent financial health updates

No updates

Recent updates

evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Mar 20
evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Apr 25
Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

Mar 26
Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Mar 05
evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Feb 12
Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Jan 25
Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Jan 07
Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Is evertex fabrinology (TPE:1470) Headed For Trouble?

Dec 20
Is evertex fabrinology (TPE:1470) Headed For Trouble?

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Dec 02
evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Financial Position Analysis

Short Term Liabilities: 1470's short term assets (NT$655.6M) exceed its short term liabilities (NT$148.9M).

Long Term Liabilities: 1470's short term assets (NT$655.6M) exceed its long term liabilities (NT$11.2M).


Debt to Equity History and Analysis

Debt Level: 1470 has more cash than its total debt.

Reducing Debt: 1470's debt to equity ratio has reduced from 4.8% to 3.6% over the past 5 years.

Debt Coverage: 1470's debt is well covered by operating cash flow (413.6%).

Interest Coverage: 1470 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.